WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke AVENIO wurde als Wortmarke am 24.02.2016 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1313134 |
| Registernummer | 302016001284 |
| Länder | 
|
| Basismarke |
Nr. 30 2016 001 284,
16. Februar 2016
|
| Anmeldedatum | 24. Februar 2016 |
| Ablaufdatum | 24. Februar 2026 |
Markeninhaber
Sandhofer Strasse 116
68305 Mannheim
DE
68305 Mannheim
DE
Markenvertreter
4070 Basel
CH
Waren und Dienstleistungen
01
Chemical, biological and biochemical preparations for
industrial, scientific and research purposes; in vitro
diagnostic reagents for use in industry and science;
chemical additives, enzymes, reagents, organisms and
proteins for use in science, research and industry; control
solutions for calibrating and monitoring the accuracy and
function of instruments and test results; chemical reagents
for cell separation, labelling reagents; reagents for the
processing, separation, isolation, enrichment, depletion,
detection, screening, cultivation, analysis and counting of
biological material; reagents featuring magnetic beads,
namely, magnetic immunoassay, for scientific and research
purposes; monoclonal antibody reagents for scientific
purposes; chemical reagents for diagnostic tests and test
kits for the determination of genetic information for
scientific or research purposes; assays and reagents for use
in genetic research; assays and reagents for scientific or
medical research use; reagents and nucleotides for nucleic
acid sequencing for scientific or research purposes
05
Chemical, biological and biochemical preparations for
medical purposes; in vitro diagnostic reagents for clinical
or medical use; in vitro diagnostic agents, namely, reagents
and control solutions for analysis of biological samples for
medical diagnostic purposes; chemical reagents for testing
body fluids to determine fetal chromosomal abnormalities;
chemical reagents and test kits for medical, clinical and
diagnostic purposes in the fields of DNA sequencing and
genetics; diagnostic test kits consisting primarily of
reagents for nucleic acid detection and analysis
09
Scientific instruments and apparatus; laboratory devices for
use in research, science and industry; laboratory
instruments, namely, devices for analysis of nucleic acids
and for DNA sequencing; nucleic acid sequencers; imaging
devices and analyzers; apparatus for preparation,
amplification, mixing, hybridization, incubation, and
washing of scientific samples; sample loaders and bar code
readers for automated laboratory apparatus; genotyping and
gene expression microarrays, associated mapping files and
associated kits for analyzing nucleic acids for scientific,
pharmaceutical and medical research purposes; software for
scientific, pharmaceutical and medical research purposes;
computer systems and software for collecting, storing,
analyzing and reporting biological information, and for
sample tracking and managing projects, laboratory workflow
and data, for use in the fields of scientific, diagnostic
and clinical research and for clinical diagnostic purposes;
software for use in analyzing, managing and visualizing DNA
sequencing data
10
Surgical and medical apparatus and instruments; medical
apparatus and instruments for medical and diagnostic
purposes; diagnostic and analytical apparatus for medical
purposes; medical equipment, namely, devices for analyzing
nucleic acids and for DNA sequencing for the purpose of
rendering medical treatment and diagnosis
42
Scientific research and consultancy services related
thereto; scientific research and consultancy services
related thereto in the fields of genome sequence analysis
and reporting; medical research services; providing DNA
screening for scientific research purposes; providing
diagnostic services for others in the fields of science and
research related thereto; consulting services in the field
of cloud computing in the fields of life science; technical
support services, namely, infrastructure management services
for monitoring, administration and management of cloud
computing IT and application systems in the fields of life
science; computer services, namely, cloud hosting provider
services for storing, analyzing and sharing data in the
fields of life science; providing online non-downloadable
software for the custom design and ordering of assays and
reagents; design and development of laboratory instruments
and computer systems for use in science and clinical
research; consultancy, information and advisory services in
the field of analysis of biomolecules
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 09. August 2023 | 2023/32 Gaz | BX | Ablehnung |
| 04. August 2023 | 2023/32 Gaz | LV | Ablehnung |
| 28. Juli 2023 | 2023/31 Gaz | FR | Ablehnung |
| 24. Juli 2023 | 2023/30 Gaz | AT | Ablehnung |
| 13. Juli 2023 | 2023/29 Gaz | CZ | Ablehnung |
| 13. Juli 2023 | 2023/28 Gaz | SI | Ablehnung |
| 05. Juli 2023 | 2023/27 Gaz | PL | Ablehnung |
| 13. Juni 2023 | 2023/25 Gaz | Löschung | |
| 19. April 2023 | 2023/18 Gaz | FI | Ablehnung |
| 18. April 2023 | 2023/17 Gaz | IE | Ablehnung |
| 01. Februar 2023 | 2023/7 Gaz | Korrektur | |
| 21. November 2021 | 2021/48 Gaz | PH | Ablehnung |
| 26. August 2021 | 2021/35 Gaz | Korrektur | |
| 13. Juli 2021 | 2021/34 Gaz | PH | RAW: Total Invalidation |
| 01. September 2020 | 2020/37 Gaz | Korrektur | |
| 27. Februar 2020 | 2020/18 Gaz | CO | RAW: Rule 18ter(4) protected goods and services |
| 21. August 2019 | 2019/34 Gaz | GB | Ablehnung |
| 02. Juli 2019 | 2019/28 Gaz | TH | Ablehnung |
| 04. Juni 2019 | 2019/23 Gaz | LA | Ablehnung |
| 02. Mai 2019 | 2019/18 Gaz | KH | Ablehnung |
| 02. April 2019 | 2019/14 Gaz | TR | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 01. April 2019 | 2019/20 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 21. März 2019 | 2019/16 Gaz | RAW: Limitation | |
| 05. März 2019 | 2019/10 Gaz | ID | Ablehnung |
| 21. Februar 2019 | 2019/9 Gaz | MA | Ablehnung |
| 15. Januar 2019 | 2019/5 Gaz | IR | Ablehnung |
| 04. Januar 2019 | 2019/7 Gaz | RAW: Limitation | |
| 06. Dezember 2018 | 2018/50 Gaz | VN | Ablehnung |
| 04. Dezember 2018 | 2018/49 Gaz | BA | Ablehnung |
| 10. Oktober 2018 | 2018/41 Gaz | RS | Ablehnung |
| 04. Oktober 2018 | 2018/40 Gaz | KZ | Ablehnung |
| 01. Oktober 2018 | 2018/45 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 26. September 2018 | 2018/39 Gaz | UA | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 05. September 2018 | 2018/36 Gaz | CO | Ablehnung |
| 14. August 2018 | 2018/33 Gaz | UA | Ablehnung |
| 09. August 2018 | 2018/33 Gaz | IL | Ablehnung |
| 20. Juni 2018 | 2018/38 Gaz | MX | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. Mai 2018 | 2018/20 Gaz | NZ | Ablehnung |
| 09. Mai 2018 | 2018/22 Gaz | Korrektur | |
| 28. März 2018 | 2018/21 Gaz | DE | RAW: Partial Ceasing Effect |
| 01. März 2018 | 2018/9 Gaz | PH | Ablehnung |
| 04. Januar 2018 | 2018/3 Gaz | Korrektur | |
| 01. Dezember 2017 | 2017/51 Gaz | Korrektur | |
| 16. November 2017 | 2017/47 Gaz | Korrektur | |
| 08. November 2017 | 2017/45 Gaz | MX | Ablehnung |
| 02. Oktober 2017 | 2017/44 Gaz | DE | RAW: Partial Ceasing Effect |
| 14. September 2017 | 2017/39 Gaz | JP | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 24. August 2017 | 2017/38 Gaz | KR | Ablehnung |
| 24. Juli 2017 | 2017/37 Gaz | IN | Ablehnung |
| 24. Juli 2017 | 2017/30 Gaz | CH | Ablehnung |
| 20. Juni 2017 | 2017/25 Gaz | CN | Ablehnung |
| 31. Mai 2017 | 2017/23 Gaz | RU | Ablehnung |
| 09. Mai 2017 | 2017/24 Gaz | TR | Ablehnung |
| 28. April 2017 | 2017/26 Gaz | IS | Ablehnung |
| 03. April 2017 | 2017/25 Gaz | Korrektur | |
| 02. März 2017 | 2017/11 Gaz | EM | Ablehnung |
| 02. März 2017 | 2017/23 Gaz | DE | RAW: Partial Ceasing Effect |
| 13. Februar 2017 | 2017/7 Gaz | KR | Ablehnung |
| 08. Februar 2017 | 2017/22 Gaz | RAW: Limitation | |
| 26. Januar 2017 | 2017/5 Gaz | JP | Ablehnung |
| 19. Januar 2017 | 2017/5 Gaz | SG | Ablehnung |
| 11. Januar 2017 | 2017/2 Gaz | AU | Ablehnung |
| 24. Februar 2016 | 2016/40 Gaz | DE | Eintragung |
ID: 141313134